PCFPeptide Clinic Finder
Full profile

Yucca Health Review

Reviewed by Gabriel Brocklesby · Last updated

A telehealth platform connecting patients with licensed providers and U.S. pharmacies for compounded GLP-1 weight management, with strong patient-review signals and flexible payment options. Also offers NAD+ and sermorelin therapy alongside its core GLP-1 programs.

Review YuccaCompare all programs

Quick verdict

Yucca Health is most useful for users who value strong patient-review signals and can compare the 6-month pricing structure against higher month-to-month flexibility.

Sponsored link disclosure

Peptide Clinic Finder may receive compensation when users click or sign up through some provider links. We aim to keep comparisons clear, cautious, and useful, but provider details can change. This page is informational and does not provide medical advice.

Key highlights

  • 4.6 'Excellent' Trustpilot rating across 1,000+ reviews — among the strongest verified social proof in the compounded GLP-1 segment
  • Licensed providers available in all 50 states
  • Compounded medications prepared by state-licensed U.S. pharmacies
  • Asynchronous provider review — no live video consultation required
  • UPS 2-Day Air shipping
  • Cancel or change treatment at any time

Who Yucca is best for

Buyers who weight patient-review signals heavily — Yucca has one of the strongest verified review profiles in this segment, with a 4.6 Trustpilot rating across 1,000+ reviews. Also a fit for patients comfortable with a 6-month commitment in exchange for the lowest pricing tier, or who need payment flexibility (Klarna, Affirm, and Afterpay are available). The platform also offers adjacent peptide options like NAD+ and sermorelin under the same clinician relationship.

This profile is designed to help users compare the program before beginning intake. It is not a recommendation that any treatment is appropriate.

Pricing and access

Compounded semaglutide from $146/month on a 6-month plan for new patients. Compounded tirzepatide from $258/month on a 6-month plan. Standard month-to-month pricing is higher. Final pricing is shared after the intake quiz once eligibility is confirmed. BNPL available via Klarna, Affirm, and Afterpay.

Confirm your final monthly cost, commitment length, cancellation terms, and medication route after eligibility review.

Licensed providers are available in all 50 states, with treatment access depending on eligibility.

Treatment, consultation, and delivery

May offer compounded GLP-1 weight-management pathways, including semaglutide and tirzepatide, plus adjacent peptide options such as NAD+ and sermorelin.

Asynchronous provider review follows the intake process; no live video consultation is required.

UPS 2-Day Air shipping is listed for eligible prescribed treatment paths.

Yucca Health

Yucca Health is most useful for users who value strong patient-review signals and can compare the 6-month pricing structure against higher month-to-month flexibility.

Pros

  • Among the strongest published patient-review signals in this market segment
  • Lowest-tier semaglutide pricing is competitive when a 6-month commitment fits your situation
  • Broader peptide menu (NAD+, sermorelin) available beyond GLP-1
  • Published cancellation flexibility

Considerations

  • Final pricing isn't shown up-front — you complete the intake before seeing your specific monthly cost
  • Lowest advertised price requires a 6-month commitment; month-to-month is materially higher
  • No live clinician consultation — provider review is asynchronous, which some patients prefer to avoid
  • Compounded medications are not FDA-approved (standard caveat across the compounded GLP-1 segment)

Best next research paths

Compare online GLP-1 programsCompare semaglutide providers onlineRead semaglutide clinical context

Editorial transparency

PCF reviews online programs for comparison purposes only. Provider details, pricing, availability, and medication paths can change. Confirm current terms directly and consult a licensed clinician before making medical decisions.